LSU HEALTH’s LA TUMOR REGISTRY publishes up-to-date statewide cancer incidence, mortality and survival information

September 4, 2022 (Sunday) 11:00 am release

new orleans, louisiana – The Louisiana Tumor Registry of LSU Health New Orleans has published the latest volume of its annual Cancer in Louisiana monograph series. Cancer in Louisiana, Volume 37, 2015-2019documents 2015-2019 cancer incidence and mortality and 1988-2019 incidence and mortality trends in Louisiana. Survival statistics for cases diagnosed from 2008 to 2018 and followed to 2019, and prevalence of diagnosed cancer cases are also included. From January 1, 2000 to January 1, 2019.

A full report is available online. Summary information includes:

  • New diagnoses of invasive cancer averaged 26,426 per year among Louisiana residents.
  • Among all Louisianans combined, the most frequently diagnosed cancers were prostate (14.2% of all new cases), breast (13.9%), lung (13.5%), colorectal (9.2%), and kidney. (4.6%).
  • All-site cancer incidence across all racial/sex groups combined in Louisiana was significantly higher than the corresponding cancer incidence in the country.
  • The seven parish industrial corridors (Ascension, East Baton Rouge, Iberville, St. Charles, St. James, St. John the Baptist, and West Baton Rouge parishes) had significantly higher rates of all cancers combined among white males. than the statewide rate. All cancer rates among black men, white women, and black women combined were not significantly different from those in Louisiana.
  • In the 11 parochial industrial corridors (the parishes of Ascension, East Baton Rouge, Iberville, Jefferson, Orleans, Plaquemins, St. Bernard, St. Charles, St. James, St. John the Baptist, and West Baton Rouge), incidence was All cancers combined by gender group were significantly lower than the statewide incidence.
  • The Louisiana incidence for all sites combined children and adolescents (ages 0–19 years) was lower than the US incidence for both boys and girls, but only the girls had a significantly lower incidence. Tumors of the central nervous system are the most common cancers among children and adolescents in Louisiana.
  • Tobacco-related cancer incidence in Louisiana is significantly higher than in the United States for all racial and gender groups.
  • Obesity-related cancer incidence is significantly higher in Louisiana than in the United States for the four major racial groups, except for white female incidence, which is not significantly different from national rates .
  • An average of 9,385 people died from cancer in Louisiana each year from 2015 to 2019.
  • For all Louisiana residents combined, cancer mortality rates are: lung cancer (26.9% of all cancer deaths), colorectal cancer (9.2%), pancreatic cancer (7.3%), breast cancer It was highest in cancer (7.1%) and liver/cholangiocarcinoma (5.5%). ).
  • Statewide, mortality rates for all sites combined were significantly higher than their national counterparts in each of the four major racial/gender groups. Lung, liver, pancreatic, and renal mortality rates was significantly higher in Louisiana than in the United States for all four racial groups.
  • Five-year relative survival rates for all cancers diagnosed in Louisiana combined between 2008 and 2018 showed a steady decline by summary stage at diagnosis in men ( 87.1%, 57.5%, and 24.8% for local, local, and long-term, respectively). Women of both races (87.1%, 64.4%, and 27.3%, respectively).

The report includes notes on interpreting the data.

  • Cancer incidence summaries for regions within a state (regions, industrial corridors, parishes, etc.) are not representative of cancer incidence in subset populations within that region, such as fenceline communities. Fenceline communities (communities adjacent to or near industrial facilities) are much smaller geographic areas. To study the impact of industrial facilities on cancer risk, detailed studies that consider facility-specific exposures, confounding variables, disease latencies, sampling errors, and systematic and random errors should be conducted. Such studies are beyond population-based cancer registry data and the inherent responsibilities of the LTR.
  • The absence of significantly higher cancer incidence in census tracts, parishes, communities, etc. does not indicate the absence of problems related to environmental exposure in small geographic areas such as fenceline communities. There is none.
  • Besides cancer, there are many other compounds for which exposure to chemicals can manifest itself as a variety of diseases.
  • Health statistics are influenced not only by the external environment, but also by other risk factors, including confounders.
  • Some cancers have a long latency period, which means that it takes years or decades from the time they develop to a diagnosis, so the incidence of cancer in a particular area is not significantly higher. and is acceptable under current environmental conditions. This factor is further complicated when the population is mobile due to natural disasters, the search for employment opportunities, or the need for specialized medical care that is not locally available. The incubation period for some cancers he can be as long as 40 years.
  • Small population sizes often lack statistical power.

“Cancer is more than the COVID-19 pandemic,” said Xiao-Cheng Wu, M.D., MPH, CTR, professor and director of the Louisiana Tumor Registry at LSU Health New Orleans School of Public Health. “According to JAMA, cancer deaths in the United States in 2020 and 2021 were 73% and 32% higher than those from COVID-19, respectively. Despite numerous barriers and obstacles, the LTR staff remains committed to its mission of providing complete, high-quality, and timely data.Without their dedicated efforts, the data collection We would not have been able to publish this monograph on time.

LSU Health New Orleans School of Public Health’s Louisiana Tumor Registry is one of only 21 cancer registries in the nation that make up the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. It is considered one of the leading cancer registries in the United States and has received the top award for the quality and completeness of its data from the National Cancer Institute for the past 13 consecutive years.


LSU Health Science Center New Orleans Educate health care professionals in Louisiana. LSU Health New Orleans, the state’s premier health sciences university, includes a medical school with campuses in Baton Rouge and Lafayette, the state’s only dental school, Louisiana’s only public public health school, and allied health professions, nursing There are undergraduate and graduate schools. the study. LSU Health New Orleans faculty care for patients in public and private hospitals and clinics throughout the region. A pioneer in bioscience research in many areas of the global arena, his LSU Health New Orleans research operations create jobs and enormous economic impact. LSU Health New Orleans faculty and staff continue to make life-saving discoveries and work to prevent, advance treatments, or cure disease. For more information, please visit the following URL:,

Source link

By admin1